30.06.2013 Views

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

How does the operation of PHARMAC's 'Community Exceptional ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

should be set aside. The third ground for claim was that PHARMAC declined to<br />

treat <strong>the</strong> plaintiffs fairly in denying <strong>the</strong>m an <strong>Exceptional</strong> Circumstances subsidy<br />

for Herceptin. In so doing, PHARMAC denied <strong>the</strong>m entitlement to receive<br />

twelve months treatment <strong>of</strong> Herceptin. This was ‘unfair’ and ‘unjust’ and<br />

<strong>of</strong>fended <strong>the</strong> complainants’ right to natural justice as contained in <strong>the</strong> New<br />

Zealand Bill <strong>of</strong> Rights Act 1990.<br />

The lawfulness <strong>of</strong> <strong>the</strong> first two claims was challenged for multiple reasons. The<br />

plaintiffs argued that PHARMAC had failed to perform its statutory duty. The<br />

claim accused PHARMAC <strong>of</strong> acting ultra vires 47 <strong>of</strong> its statutory powers in<br />

creating operating policies and procedures. They claimed that in turn, PTAC<br />

acted ultra vires in giving <strong>the</strong> advice it did. Helen Cull advised <strong>the</strong> Court that<br />

PHARMAC required PTAC to act “under its direction” so that PTAC’s advice<br />

was unlawful and that PHARMAC itself acted under a direction or a dictation.<br />

DHBs were also cited because PHARMAC had sought <strong>the</strong>ir agreement to <strong>the</strong><br />

recommendation not to fund treatment <strong>of</strong> Herceptin for a twelve month course.<br />

The plaintiffs also claimed that PHARMAC had failed to take into account<br />

relevant considerations and took into account irrelevant considerations. They<br />

claimed that PHARMAC pursued a rigid pre-determined policy or plan, so as to<br />

fetter its statutory discretion and function and in so doing, it acted in breach <strong>of</strong><br />

<strong>the</strong> plaintiffs’ legitimate expectation.<br />

The claim fur<strong>the</strong>r cited grounds for <strong>the</strong> decision to fund Herceptin for nine<br />

weeks and not twelve months, that PHARMAC acted unfairly and denied<br />

“natural justice” to <strong>the</strong> plaintiffs. This was because <strong>the</strong>y expected to be<br />

consulted through groups to which <strong>the</strong>y were aligned, before <strong>the</strong> decisions were<br />

made. They claimed that PHARMAC acted with procedural and substantive<br />

unfairness, made decisions that were unreasonable and/or irrational. Ano<strong>the</strong>r<br />

claim was that PHARMAC had breached <strong>the</strong> plaintiffs’ rights to natural justice<br />

as contained in s27(1) <strong>of</strong> <strong>the</strong> New Zealand Bill <strong>of</strong> Rights Act 1990<br />

The plaintiffs’ third claim related to PHARMAC declining to treat <strong>the</strong>m under <strong>the</strong><br />

<strong>Exceptional</strong> Circumstances policy. This would have entitled <strong>the</strong> plaintiffs to<br />

avail <strong>the</strong>mselves <strong>of</strong> <strong>the</strong> individual subsidy (funding) for twelve months for<br />

47 Ultra vires means “without powers”. A narrow interpretation <strong>of</strong> ultra vires means an administrator or entity acted<br />

without <strong>the</strong> statutory authority to do so. A broader interpretation refers to a general abuse <strong>of</strong> power by a government<br />

agency.<br />

130

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!